AbbVie Inc., Alma Lasers GmbH, AngioDynamics Inc., Bausch Health Co Inc., Boston Scientific Corp., Candela Corp, Cutera Inc., Cynosure LLC, El.

Source: https://www.prnewswire.com/news-releases/energy-based-non-invasive-medical-aesthetic-treatment-system-market-size-to-grow-by-usd-1-841-74-million-from-2022-to-2027-growth-driven-by-rising-awareness---technavio-301716666.html

Bausch Health Co Inc. - The company offers contact lens solution under the brand Clear Care Plus Solutions, which help in cleaning and disinfecting lenses.

Source: https://www.prnewswire.com/news-releases/contact-lens-solutions-market-to-grow-at-a-cagr-of-3-18-from-2021-to-2026--driven-by-the-increased-preference-for-contact-lenses-over-spectacles---technavio-301783438.html

Bausch + Lomb is expanding its ophthalmology portfolio and pipeline, paying Novartis $1.75 billion to acquire a commercialized drug for dry eye disease along with two experimental eye products.

Source: https://medcitynews.com/2023/06/bausch-lomb-acquisition-dry-eye-disease-novartis/

Finally, NewEdge Advisors LLC bought a new position in Bausch Health Companies during the second quarter valued at about $95,000.

Source: https://www.etfdailynews.com/2023/03/01/aviva-plc-trims-stock-holdings-in-bausch-health-companies-inc-nysebhc/

Throughout the Class Period, Defendants repeatedly described the B+L spinoff as an attempt to reduce Bausch's debt and said the spinoff was in the best interest of Bausch shareholders.

Source: https://www.marketscreener.com/quote/stock/BAUSCH-HEALTH-COMPANIES-I-44965075/news/Kessler-Topaz-Meltzer-Check-LLP-Reminds-BHC-Investors-of-September-25-2023-Deadline-in-Securitie-44761163/?utm_medium=RSS&utm_content=20230902

Wolverine Asset Management LLC acquired a new stake in shares of Bausch + Lomb during the fourth quarter worth $977,000.

Source: https://www.etfdailynews.com/2023/05/07/barclays-increases-bausch-lomb-nyseblco-price-target-to-18-00/